Source:http://linkedlifedata.com/resource/pubmed/id/15477656
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2004-10-12
|
pubmed:abstractText |
Natural killer T (NKT) cells are a unique subset of T lymphocytes that share receptor structures and properties with conventional T lymphocytes and natural killer (NK) cells. NKT cells are specific for glycolipid antigens such as the marine sponge-derived agent alpha-galactosylceramide (alpha-GalCer) presented by the major histocompatibility complex (MHC) class I-like molecule CD1d. My laboratory has evaluated the function of NKT cells by generating and analyzing CD1d-deficient mice. These studies showed that CD1d expression is required for NKT cell development, but not absolutely necessary for the generation of polarized T helper (Th) cell responses. Further, we have studied the in vivo response of NKT cells to alpha-GalCer stimulation and the capacity of alpha-GalCer to modulate innate and adaptive immune responses. Our results revealed that, quickly following administration of alpha-GalCer, NKT cells expand and produce cytokines, trans-activate a variety of innate and adaptive immune cells, and promote Th2 responses that are capable of suppressing Th1-dominant autoimmunity. Our findings indicate that NKT cells play a regulatory role in the immune response and that specific activation of these cells may be exploited for therapeutic purposes.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD1,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD1d,
http://linkedlifedata.com/resource/pubmed/chemical/CD1D protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Galactosylceramides,
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class I,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-galactosylceramide
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0257-277X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
139-53
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15477656-Animals,
pubmed-meshheading:15477656-Antigen Presentation,
pubmed-meshheading:15477656-Antigens, CD1,
pubmed-meshheading:15477656-Antigens, CD1d,
pubmed-meshheading:15477656-Autoimmunity,
pubmed-meshheading:15477656-Cytokines,
pubmed-meshheading:15477656-Galactosylceramides,
pubmed-meshheading:15477656-Histocompatibility Antigens Class I,
pubmed-meshheading:15477656-Humans,
pubmed-meshheading:15477656-Immunity, Innate,
pubmed-meshheading:15477656-Killer Cells, Natural,
pubmed-meshheading:15477656-Lymphocyte Activation,
pubmed-meshheading:15477656-Mice,
pubmed-meshheading:15477656-Mice, Knockout,
pubmed-meshheading:15477656-Th1 Cells,
pubmed-meshheading:15477656-Th2 Cells
|
pubmed:year |
2004
|
pubmed:articleTitle |
Regulation of immune responses by CD1d-restricted natural killer T cells.
|
pubmed:affiliation |
Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232-2363, USA. luc.van.kaer@vanderbilt.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Review,
Research Support, Non-U.S. Gov't
|